Expression of transforming growth factor-β1 and transforming growth factor-β type-II receptor mRNA in papillary thyroid carcinoma

Hormone and Metabolic Research

Volumn 30, Issue 10, 1998, Pages 624-628

  Matoba, H ^a   Sugano, S ^b   Yamaguchi, N ^b   Miyachi, Y ^a  

^a TOHO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

MRNA; Papillary Thyroid Carcinoma; Transforming Growth Factor Type Il Receptor; Transforming Growth Factor 1

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; ARTICLE; CANCER SIZE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 0031724669     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978946     Document Type: Article

References (19)

1. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701-5
2. Bascom CC, Sipes NJ, Coffey RJ, Moses HL. Regulation of epithelial cell proliferation by transforming growth factors. J Cell Biochem 1989; 39: 25-32
3. 1 response and p53 expression in thyroid epithelial cell transformation. Mol Cell Endocrinol 1991; 76: 13-21
4. Laiho M, Weis FMB, Boyd FT, Ignotz RA, Massagué J. Responsiveness to transforming growth factor-β (TGF-β) restored by genetic complementation between cells defective in TGF-β receptors I and II. J Biol Chem 1991; 266: 9108-12
5. Park K, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB, Sporn MB. Genetic changes in the transforming growth factor-β (TGF-β) Type-II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 1994; 91: 8772-6
6. The Japanese Society of Thyroid Surgery. General Rules for the Description of Thyroid Cancer. Tokyo: Kanehara Publishing Co, 1996; 5th ed.
7. Lee CC, Wu X, Gibbs RA, Cook RG, Muzny DM, Caskey CT. Generation of cDNA probes directed by amino acid sequence: Cloning of urate oxidase. Science 1988; 239: 1288-91
8. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. New York: Cold Spring Harbor Ltd., 1989; 2nd ed.: 712-5
9. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-7
10. Roberts AB, Sporn MB. The transforming growth factor-βs. In: Peptide growth factors and their receptor I. Heidelberg: Springer-Verlag LTD, 1990: 419-72
11. 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 1990; 61: 777-85
12. cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phasegrowth arrest. Mol Cell Biol 1991; 11: 1185-94
13. Masood S, Auguste LJ, Westerband A, Belluco C, Valderama E, Attie J. Differential oncogenic expression in thyroid follicular and Hürthle cell carcinomas. Am J Surg 1993; 166: 366-8
14. Yoshida K, Yokozaki H, Niimoto M, Ito H, Ito M, Tahara E. Expression of TGF-β and procollagen type I and type III in human gastric carcinomas. Int J Cancer 1989; 44: 394-8
15. 1 to the advancing edge of primary tumors and to lymph node metastases of human mammary carcinoma. Am J Pathol 1993; 143: 381-9
16. Kimchi A, Wang XF, Weinberg RA, Cheifetz S, Massagué J. Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science 1988; 240: 196-8
17. Kadin ME, Cavaille-Coll MW, Gertz R, Massagué J, Cheifetz S, George D. Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc Natl Acad Sci USA 1994; 91: 6002-6
18. Inagaki M, Moustakas A, Lin HY, Lodish HF, Carr BI. Growth inhibition by transforming growth factor-β (TGF-β) type 1 is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc Natl Acad Sci USA 1993; 90: 5359-63
19. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV. Inactivation of the type-II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995; 268: 1336-8